Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nexium in pediatric GERD (1-11 years)
NCT00228527Phase 4Completed
- Sponsor
- AstraZeneca
- Start
- Oct 2004
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 4 trial of esomeprazole in gastroesophageal reflux disease (GERD), erosive esophagitis (EE), sponsored by AstraZeneca. Started Oct 2004; status: completed.
02
Drugs
esomeprazole
03
Conditions
gastroesophageal reflux disease (GERD)erosive esophagitis (EE)
Beyond the preview
Go deeper on NCT00228527.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00228527.